Vasodilatory mechanism of unoprostone isopropyl on isolated rabbit ciliary artery.
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D019842:Ciliary Arteries / Q000187:drug effects*; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006162:Guanylate Cyclase; D006632:Histamine / Q000494:pharmacology; D007537:Isometric Contraction; D051036:Large-Conductance Calcium-Activated Potassium Channels; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D010069:Oxadiazoles / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D024681:Potassium Channels, Calcium-Activated / Q000187:drug effects; D011810:Quinoxalines / Q000494:pharmacology; D011817:Rabbits; D014664:Vasodilation / Q000502:physiology*
C095284:1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one; D000067956:Adenylyl Cyclase Inhibitors; D000959:Antihypertensive Agents; D004791:Enzyme Inhibitors; D051036:Large-Conductance Calcium-Activated Potassium Channels; D010069:Oxadiazoles; D010455:Peptides; D024681:Potassium Channels, Calcium-Activated; D011810:Quinoxalines; C017759:9-(tetrahydro-2-furyl)-adenine; C072630:isopropyl unoprostone; C064719:iberiotoxin; D006632:Histamine; D015237:Dinoprost; D006162:Guanylate Cyclase; D000225:Adenine